✦ LIBER ✦
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
✍ Scribed by H. Wildiers; C. Fontaine; P. Vuylsteke; M. Martens; J. L. Canon; W. Wynendaele; C. Focan; J. De Greve; P. Squifflet; R. Paridaens
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 203 KB
- Volume
- 123
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.